| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $14.69B | -4.6% |
| Cost of Revenue | $13.76B | -4.2% |
| Gross Profit | $928.0M | -10.2% |
| R&D Expense | $372.0M | +2.8% |
| SG&A Expense | $507.0M | -8.5% |
| Operating Income | $343.0M | -34.4% |
| Interest Expense | $187.0M | +41.7% |
| Pre-tax Income | $133.0M | -54.9% |
| Income Tax | $32.0M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.90B | +1.2% |
| Inventory | $758.0M | -9.9% |
| Current Assets | $4.09B | -5.3% |
| Total Assets | $9.35B | -0.8% |
| Current Liabilities | $3.68B | -1.6% |
| Long-term Debt | $2.40B | -0.2% |
| Stockholders' Equity | $2.13B | -4.2% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $543.0M | -18.6% |
| Investing Cash Flow | -$253.0M | -10.5% |
| Financing Cash Flow | -$502.0M | -85.2% |
| — |
| Net Income | $18.0M | -91.2% |
| EPS (Basic) | $0.20 | -90.8% |
| EPS (Diluted) | $0.20 | -90.7% |